Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 17, 2024Advanced ScienceOpen Access

Totally Caged Type I Pro‐Photosensitizer for Oxygen‐Independent Synergistic Phototherapy of Hypoxic Tumors

View Full Paper
Ask AI
Bookmark
Share

Authors

QZQin ZengXLXipeng LiJLJiajun Li

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zeng et al. (2024) studied this question.

synapsesocial.com/papers/68e64544b6db6435875d72cahttps://doi.org/10.1002/advs.202400462
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Targeted Photoredox System under a Hypoxic Environment to Evoke Photodynamic Immunotherapy2025 · 8 citations
  2. 2Unlocking Phthalonitrile‐Based Type I Photosensitizer Through D‐A Modulation to Promote Electron Transfer2026
  3. 3Combining Type I&II Photosensitizer With Hypoxia‐Activated Prodrug Enables Oxygen‐Unrestricted Synergistic Photocatalytic Therapy2026
  4. 4A Closed‐Loop Hybrid Discovery System of Type I Photosensitizers for Hypoxic Tumor Therapy2025 · 2 citations
  5. 5Achieving High‐Efficiency Type I Multimodal Photosensitizers via a Synergistic Rigidity‐Flexibility Strategy for Hypoxia‐Resistant Tumor Therapy2026